This post was originally published by Indiana University. Click here to read the original article. The IU Impact: We are advancing bioscience research and innovation, commercialization, industry collaboration and workforce development to grow Indiana’s life sciences economy and improve lives across the state. Indiana is a thriving hub of bioscience innovation, recognized globally as a leader in areas like drug discovery, orthopedics, medical devices, radiopharmaceuticals and neuroscience research. At the center of this momentum is Indiana University, where faculty, staff and students are harnessing IU’s $1 billion research enterprise to strengthen Indiana’s booming $99 billion life sciences economy. In 2023, IU President Pamela Whitten announced a historic investment to accelerate bioscience innovation and improve human health. That commitment was further cemented in 2024 with the launch of the IU Launch Accelerator for Biosciences. Supported by a $138 million Lilly Endowment Inc. grant, IU LAB [...]

This post was originally published by Indiana University. Click here to read the original article. Collaboration aims to build best-in-class clinical trial innovation ecosystem in Indiana while strengthening Alzheimer’s disease clinical care and research and supporting life sciences talent development INDIANAPOLIS — A new agreement under which Eli Lilly and Company will provide up to $40 million to Indiana University aims to expand access to clinical trials in Indiana, giving patients a critical pathway to Lilly’s latest investigational and innovative medicines while surrounding them with exceptional care. The agreement builds on a decades-long partnership between the two entities and focuses on creating a best-in-class system for clinical trial innovation, strengthening Alzheimer’s disease clinical care and research, and developing the future scientific and clinical talent for Indiana’s growing life sciences sector. The five-year agreement leverages IU’s research and clinical expertise [...]